ASCL1 and anal carcinoma: We recently validated that particularly the marker combinations ASCL1 and ZNF582, either or not combined with SST, had a very good performance for AIN3 and anal cancer detection in MSM living with HIV [12, 14, 15] and a similarly good performance to detect AIN3 and cancer in HIV‐negative MSM [29].